I read the email from the medical team of my urologist who performed the operation. But then I read the attached...

Your Pathology Report: The Apex Finding Explained

Thank you for bringing this to my attention. You've identified an important detail that deserves careful explanation. Let me break down exactly what the apex finding means and why your surgical team's overall assessment remains very positive.

---

The Apex Finding: What Your Report Says

Your pathology report contains this specific statement about the apex (tip) of the prostate:

"Στις τομές της κορυφής παρατηρούνται καρκινικά στοιχεία που περιοχικά φτάνουν στο σημασμένο όριο εκτομής."

Translation: "In the sections of the apex, cancer elements are observed that locally reach the marked surgical margin."

---

Understanding Surgical Margins in Prostate Cancer

What Are Surgical Margins?

According to NCCN Guidelines for Prostate Cancer, surgical margins are the edges of tissue removed during surgery. The pathologist examines whether cancer cells reach these edges.

Margin Status Categories:

| Status | Definition | Clinical Meaning | |---|---|---| | Negative (Clear) | Cancer does NOT reach the edge | ✅ All cancer removed | | Positive (Involved) | Cancer DOES reach the edge | ⚠️ Possible residual cancer | | Close | Cancer very near edge (<1mm) | ⚠️ Borderline |

---

Your Specific Apex Finding: Detailed Analysis

What Your Report Actually Says

Your pathology report states cancer reaches the margin only at the apex and only locally (in a limited area):

Key phrases from your report:

1. "περιοχικά φτάνουν" = "locally reach" (not throughout)
2. "στις τομές της κορυφής" = "in the sections of the apex" (specific location)
3. "Το όριο εκτομής του αυχένα... ελέγχεται ελεύθερο" = "The neck margin is clear" (other margins are negative)
4. "τα περιμετρικά όρια του προστάτη... ελέγχονται ελεύθερα" = "The peripheral margins are clear"
5. "οι σπερματοδόχες κύστεις/σπερματικοί πόροι ελέγχονται ελεύθερα" = "Seminal vesicles/ducts are clear"

What [facility removed]ally

Your margin status is:

✅ Negative margins EXCEPT at apex ⚠️ Positive margin at apex only

This is technically a positive margin, but with important context:

| Aspect | Your Situation | Significance | |---|---|---| | Location | Apex only (tip of prostate) | Limited area | | Extent | Local/focal involvement | Not extensive | | Other margins | All clear (neck, peripheral, seminal vesicles) | Favorable | | Extraprostatic extension | "No clear EPE" | Cancer didn't break through capsule | | Overall stage | pT2 | Confined to prostate |

---

Why This Finding Matters—And Why It Doesn't Change Your Prognosis Dramatically

The Clinical Significance of Apex Involvement

According to NCCN Guidelines for Prostate Cancer and American Cancer Society data:

Positive margins occur in:

• 10-30% of radical prostatectomy specimens
• More common with intermediate-risk disease
• Associated with slightly higher recurrence risk

However, your specific situation is favorable because:

1. Limited location: Only at apex, not elsewhere
2. Focal involvement: Not extensive
3. No extraprostatic extension: Cancer didn't break through capsule
4. pT2 stage maintained: Still confined to prostate
5. Other margins clear: Neck, peripheral, seminal vesicles all negative

---

Comparing Your Two Reports

You received two communications about your pathology:

Email from Surgical Team (May 9)

Stated:

• "χωρίς εξωπροστατική επέκταση" (without extraprostatic extension)
• pT2 stage
• "Particularly positive prognostic indicator"

Detailed Pathology Report (May 8)

Reveals:

• Positive margin at apex
• All other margins negative
• pT2 stage confirmed
• No extraprostatic extension confirmed

Why the difference in emphasis?

The surgical team's email focused on the overall favorable features (pT2, no EPE, complete removal). The detailed pathology report provides complete technical details, including the apex margin finding.

Both are accurate. The apex finding is real but doesn't negate the overall favorable prognosis.

---

What This Means for Your Prognosis

Impact on Recurrence Risk

According to NCCN Guidelines, positive margins increase biochemical recurrence risk, but the magnitude depends on:

Your favorable factors:

• ✓ Limited margin involvement (apex only)
• ✓ pT2 stage (confined to prostate)
• ✓ No extraprostatic extension
• ✓ Gleason 3+4=7 (intermediate, not high-grade)
• ✓ Small tumor volume (<5% each lobe)

Estimated impact:

• Without positive margin: ~10-15% biochemical recurrence at 5 years
• With focal apex margin: ~15-25% biochemical recurrence at 5 years
• Difference: Modest increase, not dramatic

Bottom line: Your positive apex margin increases recurrence risk modestly, but your overall prognosis remains very favorable.

---

What Happens Next: Your Monitoring Strategy

PSA Monitoring (Your Current Plan)

Your surgical team's PSA monitoring schedule is appropriate and important:

First PSA (40 days post-op):

• Should be undetectable (<0.1 ng/mL)
• If undetectable: Excellent sign, suggests complete cancer removal

Ongoing monitoring (every 3 months for 2 years):

• Why this matters: Early detection of PSA rise allows intervention
• What to watch for: PSA >0.1 ng/mL or rising trend

If PSA Remains Undetectable

✅ Excellent outcome — suggests apex margin involvement didn't leave residual cancer

• Continue routine monitoring
• Very low recurrence risk
• Prognosis remains excellent

If PSA Becomes Detectable or Rises

⚠️ Biochemical recurrence — suggests possible residual cancer from apex margin

• Requires imaging (PSMA-PET scan)
• May need salvage radiation therapy
• Still highly treatable

---

Critical Questions for Your Urologist

Schedule a follow-up appointment and ask these specific questions:

About the Apex Margin:

1. "My pathology report shows cancer reaching the surgical margin at the apex. How does this affect my recurrence risk compared to completely negative margins?"

2. "Was the apex margin involvement focal (limited area) or extensive? What does this mean for my prognosis?"

3. "Given the apex margin finding, do you recommend any additional treatment now, or should we monitor with PSA?"

About Salvage Therapy Options:

1. "If my PSA becomes detectable or rises, what are my salvage therapy options?"

   • Salvage radiation therapy?
   • Hormone therapy?
   • Combination approach?

2. "What PSA level or PSA doubling time would trigger salvage therapy recommendations?"

About Monitoring:

1. "Should I have any additional imaging now (PSMA-PET, MRI) given the apex margin finding, or should we wait for PSA results?"

2. "How often should I have PSA testing, and for how long?"

---

Salvage Therapy Options (If Needed)

According to NCCN Guidelines for Prostate Cancer, if biochemical recurrence occurs, options include: